# Embassy Bancorp, Inc.: overview EMYB · OTC · CIK 1449794 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/emyb.md) · [Financials](/companies/emyb/financials.md) · [Filings](/companies/emyb/filings.md) · [Insiders](/companies/emyb/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.36](/filings/0001449794-25-000035.md) | not reported | [0.38](/filings/0001449794-26-000009.md) | [0.45](/filings/0001449794-26-000028.md) | [0.50](/filings/0001449794-25-000035.md) | not reported | [0.50](/filings/0001449794-26-000009.md) | [0.56](/filings/0001449794-26-000028.md) | | Free cash flow | $k | [5,512 d](/filings/0001449794-25-000035.md) | [1,914 d](/filings/0001449794-26-000003.md) | [2,606](/filings/0001449794-26-000009.md) | [1,970 d](/filings/0001449794-26-000028.md) | [3,869 d](/filings/0001449794-25-000035.md) | [3,756 d](/filings/0001449794-26-000003.md) | [4,656](/filings/0001449794-26-000009.md) | [2,938 d](/filings/0001449794-26-000028.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [2.22](/filings/0001449794-23-000007.md) | [2.34](/filings/0001449794-24-000003.md) | [1.67](/filings/0001449794-25-000002.md) | [1.37](/filings/0001449794-26-000003.md) | [1.79](/filings/0001449794-26-000003.md) | | Free cash flow | $m | [13.7](/filings/0001449794-23-000007.md) | [19.2](/filings/0001449794-24-000003.md) | [18.7](/filings/0001449794-25-000002.md) | [9.2](/filings/0001449794-26-000003.md) | [12.2](/filings/0001449794-26-000003.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/emyb/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Siena Capital Partners GP, LLC](/funds/1694886.md) | 2026-06-30 | $3.3m | 152,639 | | Unchanged | | [PHILADELPHIA TRUST CO](/funds/1110806.md) | 2026-06-30 | $6.4k | 295,906 | | Unchanged | ## Recent filings [All 728 filings](/companies/emyb/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-13 | 16:32 ET | [10-Q](/filings/0001449794-26-000028.md) | Quarterly report, period 2026-06-30 | 0001449794-26-000028 | | 2026-08-11 | 10:36 ET | [8-K](/filings/0001449794-26-000025.md) | 5.02 Departure or appointment of officers or directors | 0001449794-26-000025 | | 2026-07-21 | 16:01 ET | [8-K](/filings/0001449794-26-000023.md) | 5.02 Departure or appointment of officers or directors | 0001449794-26-000023 | | 2026-06-18 | 16:04 ET | [8-K](/filings/0001449794-26-000021.md) | 5.07 Shareholder vote results | 0001449794-26-000021 | | 2026-06-17 | 17:09 ET | [8-K](/filings/0001449794-26-000019.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001449794-26-000019 | | 2026-06-17 | 16:52 ET | [8-K](/filings/0001449794-26-000016.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001449794-26-000016 | | 2026-06-01 | 16:37 ET | [8-K](/filings/0001449794-26-000012.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001449794-26-000012 | | 2026-05-13 | 15:40 ET | [10-Q](/filings/0001449794-26-000009.md) | Quarterly report, period 2026-03-31 | 0001449794-26-000009 | | 2026-04-27 | 15:06 ET | [DEF 14A](/filings/0001449794-26-000005.md) | Proxy statement, period 2026-06-17 | 0001449794-26-000005 | | 2026-03-16 | 16:04 ET | [10-K](/filings/0001449794-26-000003.md) | Annual report, period 2025-12-31 | 0001449794-26-000003 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001449794-26-000003.md), filed Mar 16, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1449794 - Tickers: EMYB - Exchange: OTC - SIC code: 6022 State Commercial Banks - State of incorporation: PA - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.